| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Chief Scientific Officer | Restricted Stock Unit | 79K | $392K | $4.96 | Jan 31, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Chief Scientific Officer |
| ZVRA | KEMPHARM, INC | Jan 9, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Chief Scientific Officer |
| ZVRA | KEMPHARM, INC | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | EVP, Research & Development |
| ZVRA | KEMPHARM, INC | Aug 20, 2021 | 1 | $0 | 4 | Aug 24, 2021 | EVP, Research & Development |